CO4410174A1 - Preparaciones farmaceuticas de cefixima - Google Patents
Preparaciones farmaceuticas de cefiximaInfo
- Publication number
- CO4410174A1 CO4410174A1 CO95023183A CO95023183A CO4410174A1 CO 4410174 A1 CO4410174 A1 CO 4410174A1 CO 95023183 A CO95023183 A CO 95023183A CO 95023183 A CO95023183 A CO 95023183A CO 4410174 A1 CO4410174 A1 CO 4410174A1
- Authority
- CO
- Colombia
- Prior art keywords
- suspensions
- weight
- pharmaceutical preparations
- pharmaceutical preparation
- cefixima
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
1. LA ELABORACION FARMACEUTICA FACILMENTE DISPER- SABLE Y QUIMICAMENTE ESTABLE EN FORMA DE SUSPEN- SIONES NO ACUOSAS QUE CONTIENEN CEFIXIMA CON CA- RACTER ACUOSO, CARACTERIZADA LA ELABORACION PORQUE LAS SUSPENSIONES ESTAN EXENTAS DE MATERIAL FLOCU- LANTE. 2. LAS PREPARACIONES FARMACEUTICAS DE CONFORMIDAD CON LA REIVINDICACION 1, CARACTERIZADAS PORQUE LAS SUSPENSIONES CONTIENEN UN MATERIAL O EXCIPIENTE FINALMENTE PULVERIZADO CON UNA DISTRIBUCION DE TA- MANO DE PARTICULA DE AL MENOS 80% EN PESO CON UN DIAMETRO MAXIMO DE 32 micras, Y UN MAXIMO DE 5% EN PESO CON UN TAMANO DE PARTICULA MAYOR DE 50 mi- cras. 7. LA UTILIZACION DE LAS PREPARACIONES FARMACEU- TICAS DE CONFORMIDAD CON UNA O MAS DE LAS REIVIN- DICACIONES ANTERIORES, CARACTERIZADA PORQUE ES PA- RA EL TRATAMIENTO DE INFECCIONES CRONICAS O AGU- DAS. 4. LA PREPARACION FARMACEUTICA DE CONFORMIDAD CON UNA O MAS DE LAS REIVINDICACIONES ANTERIORES CA- RACTERIZADA PORQUE EL PRINCIPIO ACTIVO MICRONIZADO ESTA SUSPENDIDO EN UN MEDIO DE TRIGLICERIDOS DE A- CIDOS GRASOS DE CADENA INTERMEDIA. 5. LA PREPARACION FARMACEUTICA DE CONFORMIDAD CON LA REIVINDICACION 1, CARACTERIZADA PORQUE LAS SUS- PENSIONES CONTIENEN ADICIONALMENTE UN AGENTE HU- MECTANTE EN UNA CONCENTRACION ENTRE EL 0.01 Y EL 1% EN PESO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4418957A DE4418957A1 (de) | 1994-05-31 | 1994-05-31 | Cefixim-Zubereitung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4410174A1 true CO4410174A1 (es) | 1997-01-09 |
Family
ID=6519407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO95023183A CO4410174A1 (es) | 1994-05-31 | 1995-05-30 | Preparaciones farmaceuticas de cefixima |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5776926A (es) |
| EP (1) | EP0685232B1 (es) |
| JP (1) | JPH07330607A (es) |
| KR (1) | KR950031077A (es) |
| CN (1) | CN1117383A (es) |
| AT (1) | ATE190844T1 (es) |
| AU (1) | AU694201B2 (es) |
| CA (1) | CA2150442A1 (es) |
| CO (1) | CO4410174A1 (es) |
| CZ (1) | CZ138595A3 (es) |
| DE (2) | DE4418957A1 (es) |
| DK (1) | DK0685232T3 (es) |
| ES (1) | ES2146265T3 (es) |
| FI (1) | FI952629A (es) |
| GR (1) | GR3033704T3 (es) |
| HU (1) | HU218217B (es) |
| IL (1) | IL113917A0 (es) |
| NO (1) | NO952138L (es) |
| NZ (1) | NZ272216A (es) |
| PE (1) | PE18796A1 (es) |
| PL (1) | PL308838A1 (es) |
| PT (1) | PT685232E (es) |
| SK (1) | SK72795A3 (es) |
| TW (1) | TW301610B (es) |
| ZA (1) | ZA954427B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0890359B1 (en) * | 1996-02-29 | 2002-05-02 | Fujisawa Pharmaceutical Co., Ltd. | Tablets containing beta-lactam antibiotic and process for producing the same |
| TW200404550A (en) * | 2002-07-08 | 2004-04-01 | Sankyo Co | Cepharospolin formulation for oral use |
| JP2007536378A (ja) * | 2004-05-10 | 2007-12-13 | ルピン・リミテッド | 生体利用性が強化されている新規セフィキシム医薬製剤 |
| WO2007119249A2 (en) * | 2006-04-13 | 2007-10-25 | Lupin Limited | Pharmaceutical compositions of cefixime |
| US9233112B2 (en) | 2006-04-13 | 2016-01-12 | Lupin Limited | Pharmaceutical compositions of cefixime |
| CN103301068B (zh) * | 2013-07-08 | 2014-09-10 | 广东彼迪药业有限公司 | 一种头孢克肟干混悬剂剂及其制备方法 |
| CA2914468A1 (en) * | 2013-07-18 | 2015-01-22 | Sandoz Ag | Powder mixtures for antibiotic dry syrup formulations |
| US11173163B2 (en) * | 2015-08-05 | 2021-11-16 | Cmpd Licensing, Llc | Topical antimicrobial compositions and methods of formulating the same |
| US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3996355A (en) | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
| DE3804841A1 (de) * | 1988-02-17 | 1989-08-31 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
| US5409917A (en) * | 1991-03-05 | 1995-04-25 | Marvin S. Towsend | Topical treatment of acne with cephalosporins |
-
1994
- 1994-05-31 DE DE4418957A patent/DE4418957A1/de not_active Withdrawn
-
1995
- 1995-05-24 PT PT95107930T patent/PT685232E/pt unknown
- 1995-05-24 ES ES95107930T patent/ES2146265T3/es not_active Expired - Lifetime
- 1995-05-24 AT AT95107930T patent/ATE190844T1/de not_active IP Right Cessation
- 1995-05-24 DE DE59508024T patent/DE59508024D1/de not_active Expired - Fee Related
- 1995-05-24 DK DK95107930T patent/DK0685232T3/da active
- 1995-05-24 EP EP95107930A patent/EP0685232B1/de not_active Expired - Lifetime
- 1995-05-25 JP JP7126029A patent/JPH07330607A/ja active Pending
- 1995-05-26 AU AU20335/95A patent/AU694201B2/en not_active Ceased
- 1995-05-26 PE PE1995269744A patent/PE18796A1/es not_active Application Discontinuation
- 1995-05-26 NZ NZ272216A patent/NZ272216A/en unknown
- 1995-05-29 CA CA002150442A patent/CA2150442A1/en not_active Abandoned
- 1995-05-29 TW TW084105413A patent/TW301610B/zh active
- 1995-05-29 CN CN95105585A patent/CN1117383A/zh active Pending
- 1995-05-30 KR KR1019950013788A patent/KR950031077A/ko not_active Application Discontinuation
- 1995-05-30 CZ CZ951385A patent/CZ138595A3/cs unknown
- 1995-05-30 CO CO95023183A patent/CO4410174A1/es unknown
- 1995-05-30 HU HU9501570A patent/HU218217B/hu not_active IP Right Cessation
- 1995-05-30 FI FI952629A patent/FI952629A/fi unknown
- 1995-05-30 IL IL11391795A patent/IL113917A0/xx unknown
- 1995-05-30 ZA ZA954427A patent/ZA954427B/xx unknown
- 1995-05-30 PL PL95308838A patent/PL308838A1/xx unknown
- 1995-05-30 NO NO952138A patent/NO952138L/no unknown
- 1995-05-31 SK SK727-95A patent/SK72795A3/sk unknown
-
1997
- 1997-03-03 US US08/806,757 patent/US5776926A/en not_active Expired - Fee Related
-
2000
- 2000-06-16 GR GR20000401394T patent/GR3033704T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0685232T3 (da) | 2000-08-21 |
| ATE190844T1 (de) | 2000-04-15 |
| CZ138595A3 (en) | 1996-04-17 |
| NO952138D0 (no) | 1995-05-30 |
| GR3033704T3 (en) | 2000-10-31 |
| KR950031077A (ko) | 1995-12-18 |
| PL308838A1 (en) | 1995-12-11 |
| ZA954427B (en) | 1996-01-24 |
| DE4418957A1 (de) | 1995-12-07 |
| CN1117383A (zh) | 1996-02-28 |
| FI952629A0 (fi) | 1995-05-30 |
| NZ272216A (en) | 1996-05-28 |
| SK72795A3 (en) | 1996-01-10 |
| TW301610B (es) | 1997-04-01 |
| PE18796A1 (es) | 1996-06-04 |
| HU9501570D0 (en) | 1995-07-28 |
| JPH07330607A (ja) | 1995-12-19 |
| AU2033595A (en) | 1995-12-07 |
| PT685232E (pt) | 2000-08-31 |
| AU694201B2 (en) | 1998-07-16 |
| CA2150442A1 (en) | 1995-12-01 |
| IL113917A0 (en) | 1995-08-31 |
| EP0685232B1 (de) | 2000-03-22 |
| FI952629A (fi) | 1995-12-01 |
| EP0685232A2 (de) | 1995-12-06 |
| US5776926A (en) | 1998-07-07 |
| HUT74421A (en) | 1996-12-30 |
| DE59508024D1 (de) | 2000-04-27 |
| NO952138L (no) | 1995-12-01 |
| HU218217B (hu) | 2000-06-28 |
| ES2146265T3 (es) | 2000-08-01 |
| EP0685232A3 (de) | 1996-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1923165B (zh) | 把物质释放至皮肤的方法及其中所用到的组合物 | |
| AR020288A1 (es) | Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado. | |
| BR9702362A (pt) | Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação. | |
| ES2052016T3 (es) | Composicion emulsionada. | |
| AR029655A1 (es) | Mejoras en formulaciones en pasta | |
| CO4410174A1 (es) | Preparaciones farmaceuticas de cefixima | |
| BR9610929A (pt) | Processos para liberar um ou mais polipeptídeos biologicamente ativos, e um ou mais antígenos, para regular as funções de sobrevivência, crescimento, diferenciação, efetuadora ou suscetibilidade a infeção de células ou tecidos, para refoçar uma resposta imune contra células de tumor ou uma infecção colonizado uma superfície mucosal ou tecido distante ou adjacente, para modular o tipo de resposta imune ( anticorpo versus mediada por célula) contra um agente infeccioso patogênico, para induzir a apoptose em células | |
| ATE487470T1 (de) | Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse | |
| ES2052947T3 (es) | Nueva forma unitaria, solida y porosa que comprende microparticulas y/o nanoparticulas asi como su preparacion. | |
| IT1247138B (it) | Composizione farmaceutica idrofila contenente ketoprofene sale di lisina per uso topico. | |
| PA8481901A1 (es) | Administracion de agente activo en polvo seco | |
| ES2176355T3 (es) | Formulaciones de aerosol de peptidos y proteinas. | |
| ES2193726T3 (es) | Formulaciones de aerosol medicinales. | |
| ES2045470T3 (es) | Formulaciones medicinales en aerosol. | |
| AR017984A1 (es) | Proceso para formar una composicion farmaceutica de topiramato y composicion farmaceutica de topiramato | |
| CR6656A (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| MX9300964A (es) | Metodo para reducir el mal olor en productos absorbentes y productos formados por el mismo. | |
| PT782448E (pt) | Formulacoes oticas antibacterianas nao ototoxicas nao sensibilizantes nao irritantes | |
| BR0015676A (pt) | Composição pesticida, método para controlar pestes, e, uso de uma composição de gel aerado estável em armazenamento | |
| MX9306051A (es) | Composicion desodorante en forma de barra de gel estable. | |
| AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
| BR9913782A (pt) | Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato | |
| BR9916304A (pt) | Goma de mascar contendo agentes ativos demedicamentos | |
| BR9917389A (pt) | Formulações tópicas compreendendo agentes de penetração na pele e o uso das mesmas | |
| ES2061429T1 (es) | Procedimiento y producto para el moldeado permanente del cabello. |